Evidence map›Paper›PMID 28954280›Full record

ArticleJournal of the National Cancer Institute2017

Editorial: Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk.

Konstantinos K Tsilidis, James Y Dai, Ulrike Peters

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.
James Y DaiDepartment of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.
Ulrike PetersDepartment of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece; Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, United Kingdom; Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA.

Funding

Use of Biomarkers in Diagnosis, Prognosis, Risk Prediction and Early Detection ofP01CA053996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRENTICE, ROSS L · 1991 to 2015
$9.4M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Medical Research Council MC_UU_12013/1NCI NIH HHS P01 CA053996NIH HHS S10 OD020069
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Body Mass IndexMendelian Randomization AnalysisFastingHumansInsulinPancreatic NeoplasmsPolymorphism, Single NucleotideRisk FactorsInsulin

Identifiers

PMID28954280
PMCPMC6075551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.